28 Jan 2021

Nuevos avances en Reumatología e implicaciones terapéuticas 2021

  • Rheumatology
  • Spanish
  • Online





Do you want to know the next activities activities on Reumatología?

Join our newsletter list to be updated on upcoming activities.


The progressive understanding of the human immune system and the pathophysiology of immune-mediated diseases (IMIDs) have led us to consider a large number of new targets and the identification of numerous potential therapeutic targets for patients with IMIDs. Moreover, the possible involvement of the exogenome in the activation of the immune system and its role in the different IMIDs is today one of the most interesting scientific challenges.

The different lectures, led by renowned experts, will provide a comprehensive overview of the management of rheumatoid arthritis and the spondyloarthritis family with special emphasis on all the new imaging and biomarker data useful to move towards personalized medicine. The conference will also serve to evaluate in depth the clinical and therapeutic implications of the microbiome in these diseases.



  • Jordi Gratacós

    Director of the Rheumatology Service.

    Hospital Parc Taulí, Sabadell, Spain.

  • Eduardo Collantes

    Emeritus Professor and Co-Responsible Investigator

    University of Cordoba and IMIBIC, Cordoba, Spain. 

  • José María Álvaro-Gracia

    Director of the Rheumatology Service Hospital Gregorio Marañón, Madrid.


Activity accredited by the Consell Català de Formació Continua de les Professions Sanitàries-Comisión de Formación Continuada de Sistema Nacional de Salud. 0,6 Credits. Record: 09/028749-MD.




    Your Cart
    Your cart is emptyReturn to Shop